For example, in cervical cancers and in breast cancer cells, the levels of miRNA181a, or miRNA29a, modulate the expression levels of PTEN, resulting in decreased rates of proliferation and migration or increased apoptosis [50, 51]. This evidence concerns the gene PTEN and cervical cancer.